PEAK: Plasmid Evolution and Antimicrobial resistance in Klebsiella pneumoniae

  • Funded by The Research Council of Norway (RCN)
  • Total publications:0 publications

Grant number: 356873

Grant search

Key facts

  • Disease

    Bacterial infection caused by Klebsiella pneumonia
  • Start & end year

    2025
    2029
  • Known Financial Commitments (USD)

    $517,716.73
  • Funder

    The Research Council of Norway (RCN)
  • Principal Investigator

    Harry Thorpe
  • Research Location

    Norway
  • Lead Research Institution

    UNIVERSITETET I OSLO, DET MEDISINSKE FAKULTET, Institutt for medisinske basalfag
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Antimicrobial resistance (AMR) is a serious threat to public health that is predicted to get worse in the future. One of the most common methods that bacteria use to resist antibiotics is to acquire resistance genes. These are often located on pieces of DNA called plasmids. Plasmids carrying resistance genes are more common in clinical settings than in the general population, and understanding why we have this difference is very important for understanding how resistant bacteria spread. However, plasmids evolve quickly and can spread between different strains of bacteria. This makes it difficult for us to classify and monitor them. In PEAK, we will use new sequencing technologies and develop new methods to research how plasmids evolve and spread, with a focus on the important pathogenic bacterium Klebsiella pneumoniae. We will develop new methods to classify plasmids and analyze the genetic differences between plasmid groups. We will then use these plasmid groups to research how plasmids spread between different environments and types of Klebsiella. We will then perform detailed analyses of the genetic changes that drive the evolution of plasmids. The goal is to use the new methods and knowledge to improve surveillance, both of AMR Klebsiella pneumoniae and other bacterial strains.